+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Hemostats & Tissue Sealants Market by Product Type (Hemostats, Tissue Sealants), Material Type (Natural Materials, Synthetic Materials), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904516
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Hemostats & Tissue Sealants Market grew from USD 6.85 billion in 2024 to USD 7.69 billion in 2025. It is expected to continue growing at a CAGR of 12.36%, reaching USD 13.79 billion by 2030.

The global healthcare landscape is undergoing significant evolution, and the segment of hemostats and tissue sealants is emerging as a crucial component in modern clinical practice. Advances in technology and an increasing emphasis on minimally invasive procedures have driven demand for products that can deliver efficient blood management and effective tissue sealing. Innovation in product design, coupled with a deeper understanding of the biological processes involved in hemostasis and wound closure, has spurred the development of sophisticated solutions tailored to meet complex surgical requirements. These developments are not only enhancing patient outcomes but are also enabling hospitals, ambulatory centers, and clinics to reduce procedural times and improve overall safety standards. With stakeholders across the value chain keenly investing in research and development, the market is witnessing a transformation that highlights the value of clinical innovation, regulatory compliance, and cost-effective treatment methods. This report sets the stage by delving into the underlying trends, emerging technological advancements, and key strategic drivers that are redefining the competitive landscape of hemostats and tissue sealants on a global scale.

Transformative Shifts in the Hemostats & Tissue Sealants Landscape

Over recent years, the market for hemostats and tissue sealants has experienced transformative shifts driven by several converging factors. Advances in biomedical engineering and material science have paved the way for next-generation products that offer higher efficacy and enhanced safety profiles. The integration of digital diagnostics and real-time monitoring systems in surgical environments has further accelerated the adoption of these medical devices. While consumer demand for minimally invasive procedures continues to rise, healthcare providers are also shifting their focus towards products that reduce recovery time and limit complications. This transformation is marked by a move from conventional treatments towards innovative, patient-centric solutions that emphasize precision and performance. The evolution of surgical techniques and increasing regulatory rigor have compelled manufacturers to invest in sustained innovation, stricter quality assurance, and comprehensive clinical validation. Industry players are now rapidly adapting to these changes by optimizing their product portfolios and investing in scalable production methodologies. Overall, the shifting market dynamics are creating new opportunities for industry stakeholders to capture value through improved efficiency, enhanced product reliability, and stronger partnerships with healthcare ecosystems worldwide.

Key Segmentation Insights Across Product, Material, Application, and End User

Delving into the market segmentation reveals a complex and multi-layered distribution of opportunities across several vital dimensions. When viewed from a product type perspective, the market is analyzed through the dual lenses of hemostats and tissue sealants. Hemostats, in this context, are further categorized into active hemostats, flowable hemostats, and mechanical hemostats to address the varying needs in bleeding control. Tissue sealants are similarly disaggregated into fibrin sealants and synthetic sealants, each catering to different clinical scenarios and tissue healing requirements. Segmentation based on material type further distinguishes the market into natural and synthetic innovations. Natural materials are evaluated through distinctions such as bovine-derived and human-derived options, whereas synthetic materials are parsed into collagen-based and polymer-based solutions, reflecting advances in biocompatibility and performance. Application-based segmentation provides additional insight, separating non-surgical procedures into diagnostic procedures and minor wound sealing, alongside surgical procedures that cover cardiovascular, gastrointestinal, and general surgery. Finally, an analysis based on end user identifies key consumers ranging from ambulatory surgical centers and clinics to hospitals. These layered insights across segmentation dimensions provide a comprehensive view of the market’s structure and reinforce the notion that targeted innovation is essential for each distinct market segment.

Based on Product Type, market is studied across Hemostats and Tissue Sealants. The Hemostats is further studied across Active Hemostats, Flowable Hemostats, and Mechanical Hemostats. The Tissue Sealants is further studied across Fibrin Sealants and Synthetic Sealants.

Based on Material Type, market is studied across Natural Materials and Synthetic Materials. The Natural Materials is further studied across Bovine-Derived and Human-Derived. The Synthetic Materials is further studied across Collagen-Based and Polymer-Based.

Based on Application, market is studied across Non-Surgical Procedures and Surgical Procedures. The Non-Surgical Procedures is further studied across Diagnostic Procedures and Minor Wound Sealing. The Surgical Procedures is further studied across Cardiovascular Surgery, Gastrointestinal Surgery, and General Surgery.

Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.

Key Regional Insights: Emerging Growth in Leading Geographies

Regional dynamics play a critical role in driving market trends in the field of hemostats and tissue sealants. In the Americas, a robust healthcare infrastructure combined with strong regulatory oversight has fostered an environment ripe for technological adoption and clinical advancement. The convergence of heightened R&D activities and increased investment in healthcare facilities is fueling market growth in this region. Europe, Middle East & Africa (EMEA) exhibit a diverse mix of mature economies and emerging markets, where varying healthcare policies and spending patterns are shaping the demand for innovative medical solutions. In this region, the emphasis is on attaining operational excellence through precision technologies that meet stringent regulatory requirements. The Asia-Pacific region stands out for its rapid industrialization and expanding middle-class demographics, which are bolstering healthcare expenditure and driving demand for advanced medical devices. Here, accelerated infrastructural developments and government initiatives aimed at improving public health services are accelerating market penetration. Understanding these regional intricacies is critical for stakeholders aiming to optimize geographical strategies and align product offerings with local market demands.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Companies Shaping the Market Landscape

The evolution of the hemostats and tissue sealants market has been significantly influenced by a cadre of leading companies that have become synonymous with innovation and clinical excellence. Market leaders such as Abbott Laboratories and Baxter International Inc. have set benchmarks in product performance and reliability, while companies like B. Braun SE and Cardinal Health, Inc. have successfully leveraged their extensive global networks to ensure product accessibility. Companies including Advanced Medical Solutions Group PLC and Aegis Lifesciences Private Limited have emerged as formidable players, pushing the envelope with highly specialized solutions that cater to niche clinical requirements. Firms like Becton, Dickinson and Company, CooperSurgical, Inc., and CryoLife, Inc. are investing heavily in clinical trials and advanced research to stay ahead in terms of efficacy and safety. Major enterprises such as CSL Behring and Grifols, S.A., alongside Hemostasis, LLC and Hologic, Inc., have carved a unique market presence by offering innovative, patient-centric solutions that are well-supported by clinical data. Organizations, including Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., and prominent players in the European and Asian markets like KAKEN PHARMACEUTICAL CO., LTD. and KATSAN Katgüt Sanayi ve Tic. A.Ş., are further enhancing the competitive landscape. Additional stalwarts such as Medline Industries, LP., Medtronic PLC, Olympus Corporation, Owens & Minor, and Pfizer, Inc. reinforce the global market momentum, alongside industry leaders Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., Vivostat A/S, and Zimmer Biomet who continue to drive forward-thinking innovations.

The report delves into recent significant developments in the Hemostats & Tissue Sealants Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Medical Solutions Group PLC, Aegis Lifesciences Private Limited., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., CooperSurgical, Inc., CryoLife, Inc., CSL Behring, CuraMedical B.V., Grifols, S.A., Hemostasis, LLC, Hologic, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KAKEN PHARMACEUTICAL CO., LTD., KATSAN Katgüt Sanayi ve Tic. A.Ş., Medline Industries, LP., Medtronic PLC, Olympus Corporation, Owens & Minor, Pfizer, Inc., Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., Vivostat A/S, and Zimmer Biomet.

Actionable Recommendations for Pioneering Industry Leaders

Industry leaders must adopt a proactive approach in order to navigate the dynamic landscape of the hemostats and tissue sealants market effectively. It is imperative to invest in research and technological innovations that not only meet current clinical needs but also anticipate future market demands. Strengthening collaborations with clinical experts and regulatory bodies can enable timely product approvals and enhance market trust. Companies should also revisit their segmentation strategies to align product development with the specific needs identified across various product types, material compositions, and clinical applications. Emphasizing the importance of a robust geographical strategy and catering to region-specific trends will further consolidate market positioning. Additionally, building strategic alliances and exploring opportunities for mergers and acquisitions could prove beneficial in expanding market reach and improving cost efficiencies across the value chain. A commitment to continuous improvement and a detailed understanding of the diverse end user requirements will serve as the cornerstone for sustained industry leadership.

Navigating Opportunities in a Dynamic Market

The market for hemostats and tissue sealants stands at the cusp of significant transformation. Ongoing technological advancements, evolving clinical practices, and a keen focus on patient outcomes are converging to redefine market dynamics. By understanding both the micro-level segmentation nuances and macro-level regional trends, stakeholders can harness growth opportunities while mitigating inherent risks. The analysis underscores that strategic investments - whether in R&D, quality control, or market expansion - are fundamental to maintaining a competitive edge. Companies that quickly adapt to shifting clinical paradigms, invest in bespoke product innovations, and foster efficient operational practices are in a prime position to lead the market. The evolving landscape promises not only enhanced clinical outcomes for patients but also sustainable growth trajectories for industry players who are ready to embrace change and drive the future of medical care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of chronic disorders and need for timely surgeries
5.1.1.2. Rising demand for minimally invasive surgeries among patients
5.1.1.3. Favorable reimbursement policies for surgical interventions
5.1.2. Restraints
5.1.2.1. Low outlining quality and high costs of surgical sealants
5.1.3. Opportunities
5.1.3.1. Development of customized hemostatic and sealing solutions for specific wounds
5.1.3.2. Ongoing innovations in eco-friendly hemostat and sealant solutions
5.1.4. Challenges
5.1.4.1. Strict standards regarding the utilization of hemostats & tissue sealants
5.2. Market Segmentation Analysis
5.2.1. Product Type: Rising significance of synthetic sealants owing to their prolonged shelf life and reliability
5.2.2. Application: Expanding application of hemostats and tissue sealants among non-surgical procedures
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Hemostats & Tissue Sealants Market, by Product Type
6.1. Introduction
6.2. Hemostats
6.2.1. Active Hemostats
6.2.2. Flowable Hemostats
6.2.3. Mechanical Hemostats
6.3. Tissue Sealants
6.3.1. Fibrin Sealants
6.3.2. Synthetic Sealants
7. Hemostats & Tissue Sealants Market, by Material Type
7.1. Introduction
7.2. Natural Materials
7.2.1. Bovine-Derived
7.2.2. Human-Derived
7.3. Synthetic Materials
7.3.1. Collagen-Based
7.3.2. Polymer-Based
8. Hemostats & Tissue Sealants Market, by Application
8.1. Introduction
8.2. Non-Surgical Procedures
8.2.1. Diagnostic Procedures
8.2.2. Minor Wound Sealing
8.3. Surgical Procedures
8.3.1. Cardiovascular Surgery
8.3.2. Gastrointestinal Surgery
8.3.3. General Surgery
9. Hemostats & Tissue Sealants Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Clinics
9.4. Hospitals
10. Americas Hemostats & Tissue Sealants Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Hemostats & Tissue Sealants Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Hemostats & Tissue Sealants Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2024
13.2. FPNV Positioning Matrix, 2024
13.3. Competitive Scenario Analysis
13.3.1. Medcura secures USD 4 million funding to innovate life-saving battlefield hemostats
13.3.2. Grifols expands pediatric surgical care with FDA-approved fibrin sealant enhancing hemostasis outcomes
13.3.3. Teleflex expands market reach with Premier, Inc. through competitive hemostasis product agreements
13.3.4. Olympus Launches EndoClot Hemostatic Agents and Submucosal Injection Agent in European Markets
13.3.5. Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations
13.3.6. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
13.3.7. Team Develops Extracellular Matrix-Based Sticky Sealants For Corneal Tissue Reconstruction
13.3.8. Medcura Receives Breakthrough Device Designation for its LifeGel™ Absorbable Surgical Hemostat
13.3.9. Cresilon Closes $25 Million in Series A-4 Financing to Accelerate Global Expansion and Bring Revolutionary Hemostatic Gel to Human Health Market
13.3.10. ZEISS Receives FDA Clearance for MTLawton - A New Generation of Bipolar Forceps for Electrosurgery
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. HEMOSTATS & TISSUE SEALANTS MARKET MULTI-CURRENCY
FIGURE 2. HEMOSTATS & TISSUE SEALANTS MARKET MULTI-LANGUAGE
FIGURE 3. HEMOSTATS & TISSUE SEALANTS MARKET RESEARCH PROCESS
FIGURE 4. HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 11. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 13. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 15. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 17. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 19. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. HEMOSTATS & TISSUE SEALANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 25. HEMOSTATS & TISSUE SEALANTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HEMOSTATS & TISSUE SEALANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. HEMOSTATS & TISSUE SEALANTS MARKET DYNAMICS
TABLE 7. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY ACTIVE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FLOWABLE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MECHANICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC SEALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY BOVINE-DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HUMAN-DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COLLAGEN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MINOR WOUND SEALING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY GASTROINTESTINAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 73. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 74. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 75. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 76. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 77. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 79. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 80. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 83. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 89. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 90. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 125. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 126. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 127. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 128. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 129. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 131. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 132. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 135. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 136. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 137. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 138. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 139. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 141. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 142. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 155. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 156. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 157. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 158. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 159. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 161. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 162. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 205. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 206. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 207. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 215. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 216. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 217. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 218. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 219. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 221. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 222. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 244. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 246. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 247. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 248. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 249. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 250. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 252. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 253. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 256. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 257. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 258. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 259. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 260. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 262. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 263. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 266. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 267. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 268. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 269. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 270. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 272. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 273. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 276. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 277. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 278. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 279. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 280. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 282. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 283. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 286. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 287. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 288. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 289. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 290. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 292. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 293. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 306. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 307. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 308. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 309. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 310. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NON-SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 312. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 313. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD M

Companies Mentioned

  • Abbott Laboratories
  • Advanced Medical Solutions Group PLC
  • Aegis Lifesciences Private Limited.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • CooperSurgical, Inc.
  • CryoLife, Inc.
  • CSL Behring
  • CuraMedical B.V.
  • Grifols, S.A.
  • Hemostasis, LLC
  • Hologic, Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • KAKEN PHARMACEUTICAL CO., LTD.
  • KATSAN Katgüt Sanayi ve Tic. A.Ş.
  • Medline Industries, LP.
  • Medtronic PLC
  • Olympus Corporation
  • Owens & Minor
  • Pfizer, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • Vivostat A/S
  • Zimmer Biomet

Methodology

Loading
LOADING...

Table Information